Eric I Hsiao, MD
Pulmonary Disease · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 23
- 5 carriers
- Offices
- 2
Offices
2 locations · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
23 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hsiao’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
23 of 23 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A65453 · Current
Licensed to practise in California · since 1998 · expires 2028-06-30 · University of California, Irvine College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$51,366
Medicare paid this office $51,366 for 229 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 58 | $29,069 | $185 |
| Short return visit (20+ min) | 62 | $4,451 | $51 |
| Return visit (30+ min) | 48 | $4,178 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $3,842 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,860 | $69 |
See all 7 services
| Critical care, first 30-74 minutes | 58 | $29,069 | $185 |
| Short return visit (20+ min) | 62 | $4,451 | $51 |
| Return visit (30+ min) | 48 | $4,178 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $3,842 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,860 | $69 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,547 | $103 |
| New patient visit (45+ min) | 12 | $1,067 | $89 |
Who their Medicare patients are
229 Original Medicare patients in 2024. Average age 71 · Under 65 21% · 85 and older 13% · Women 44% · Also on Medicaid 81% · Health risk score 2.95. Above the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 75% · Diabetes 53% · Heart failure 42% · COPD 42% · Coronary heart disease 36% · Chronic kidney disease 35% · Atrial fibrillation 29% · Depression 24% · Dementia 18% · Stroke 17% · Cancer 16%.
The office billed $618,490, Medicare allowed $67,442 and paid $51,366; for 469 services of 35 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 229 | 469 | 71 | 2.95 | $618,490 | $51,366 |
| 2023 | 230 | 475 | 71 | 2.50 | $525,110 | $47,858 |
| 2022 | 179 | 348 | 71 | 2.25 | $499,901 | $46,021 |
| 2021 | 189 | 422 | 69 | 2.56 | $513,601 | $54,941 |
| 2020 | 229 | 460 | 69 | 2.72 | $610,833 | $59,804 |
| 2019 | 282 | 508 | 68 | 2.42 | $627,761 | $46,612 |
| 2018 | 265 | 515 | 68 | 2.63 | $613,041 | $52,545 |
| 2017 | 271 | 596 | 68 | 2.56 | $645,226 | $61,244 |
| 2016 | 267 | 503 | 68 | 2.05 | $444,735 | $52,383 |
| 2015 | 227 | 455 | 69 | 2.38 | $330,828 | $44,218 |
| 2014 | 312 | 588 | 68 | 1.84 | $371,309 | $55,236 |
| 2013 | 288 | 536 | 66 | 2.21 | $318,164 | $51,143 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Critical care, first 30-74 minutes | 54 | $26,715 | $201 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $3,949 | $113 |
| Short return visit (20+ min) | 50 | $3,538 | $53 |
| Return visit (30+ min) | 37 | $3,147 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $2,809 | $76 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,823 | $122 |
| Test to determine lung volumes using sensors | 21 | $186 | $9 |
| Test to examine how well the lungs exchange gases | 24 | $154 | $6 |
| Test to measure expiratory airflow and volume | 17 | $120 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 13 | $84 | $6 |
2022: 7 services
| Critical care, first 30-74 minutes | 52 | $28,988 | $213 |
| Return visit (30+ min) | 38 | $3,383 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $2,940 | $105 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,721 | $143 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,713 | $78 |
| Short return visit (20+ min) | 30 | $1,608 | $49 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $605 | $50 |
2021: 9 services
| Critical care, first 30-74 minutes | 63 | $36,102 | $224 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $4,080 | $110 |
| Return visit (30+ min) | 36 | $3,858 | $94 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $2,411 | $151 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,294 | $76 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,060 | $88 |
| Short return visit (20+ min) | 13 | $879 | $63 |
| Test to determine lung volumes using sensors | 16 | $158 | $10 |
| Test to examine how well the lungs exchange gases | 16 | $117 | $7 |
2020: 13 services
| Critical care, first 30-74 minutes | 69 | $41,209 | $230 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $3,464 | $112 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $3,055 | $139 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $2,253 | $78 |
| Telephone medical discussion with physician, 11-20 minutes | 31 | $1,579 | $45 |
| Return visit (30+ min) | 21 | $1,267 | $55 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 11 | $1,185 | $108 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $1,037 | $69 |
| Sleep study including heart rate, breathing, airflow, and effort | 15 | $555 | $37 |
| Short return visit (20+ min) | 13 | $476 | $34 |
| Test to determine lung volumes using sensors | 12 | $116 | $10 |
| Test to examine how well the lungs exchange gases | 11 | $86 | $8 |
| Test to measure expiratory airflow and volume | 13 | $79 | $6 |
2019: 13 services
| Critical care, first 30-74 minutes | 62 | $23,557 | $193 |
| Return visit (30+ min) | 65 | $4,200 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $3,788 | $92 |
| Sleep study in sleep lab (6 years or older) | 23 | $2,274 | $99 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,988 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,856 | $66 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 15 | $1,743 | $116 |
| Short return visit (20+ min) | 37 | $1,585 | $41 |
| Sleep study including heart rate, breathing, airflow, and effort | 28 | $1,025 | $35 |
| Test to determine lung volumes using sensors | 22 | $249 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 13 | $144 | $11 |
| Test to examine how well the lungs exchange gases | 17 | $142 | $8 |
| Test to measure expiratory airflow and volume | 17 | $140 | $8 |
2018: 13 services
| Critical care, first 30-74 minutes | 69 | $32,203 | $193 |
| Return visit (30+ min) | 53 | $3,532 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $3,292 | $89 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,773 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,765 | $65 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 17 | $1,602 | $94 |
| Short return visit (20+ min) | 41 | $1,459 | $35 |
| Sleep study in sleep lab (6 years or older) | 17 | $1,358 | $80 |
| Sleep study including heart rate, breathing, airflow, and effort | 14 | $389 | $28 |
| Test to determine lung volumes using sensors | 19 | $178 | $9 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 14 | $142 | $10 |
| Test to measure expiratory airflow and volume | 18 | $121 | $6 |
| Test to examine how well the lungs exchange gases | 16 | $107 | $7 |
2017: 13 services
| Critical care, first 30-74 minutes | 62 | $39,476 | $194 |
| Return visit (30+ min) | 54 | $3,670 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $3,272 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,786 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,412 | $121 |
| Sleep study in sleep lab (6 years or older) | 21 | $1,872 | $89 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 12 | $1,239 | $103 |
| Short return visit (20+ min) | 25 | $1,005 | $39 |
| Sleep study including heart rate, breathing, airflow, and effort | 18 | $943 | $52 |
| Test to determine lung volumes using sensors | 27 | $262 | $10 |
| Test to measure expiratory airflow and volume | 38 | $235 | $6 |
| Test to examine how well the lungs exchange gases | 28 | $191 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 13 | $130 | $10 |
2016: 11 services
| Critical care, first 30-74 minutes | 51 | $32,548 | $195 |
| Return visit (30+ min) | 82 | $5,756 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $2,064 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $1,929 | $60 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 18 | $1,825 | $101 |
| Sleep study in sleep lab (6 years or older) | 16 | $1,756 | $110 |
| Sleep study including heart rate, breathing, airflow, and effort | 26 | $1,320 | $51 |
| Short return visit (20+ min) | 37 | $1,277 | $35 |
| Test to determine lung volumes using sensors | 14 | $111 | $8 |
| Test to examine how well the lungs exchange gases | 12 | $74 | $6 |
| Test to measure expiratory airflow and volume | 12 | $68 | $6 |
2015: 10 services
| Critical care, first 30-74 minutes | 46 | $26,508 | $189 |
| Return visit (30+ min) | 65 | $4,102 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,156 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,557 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,425 | $89 |
| Short return visit (20+ min) | 19 | $641 | $34 |
| Test to determine lung volumes using sensors | 22 | $227 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 16 | $172 | $11 |
| Test to examine how well the lungs exchange gases | 19 | $144 | $7 |
| Test to measure expiratory airflow and volume | 19 | $126 | $6 |
2014: 11 services
| Critical care, first 30-74 minutes | 80 | $33,042 | $191 |
| Return visit (30+ min) | 77 | $5,494 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $3,625 | $64 |
| Short return visit (20+ min) | 57 | $2,337 | $41 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 23 | $2,167 | $94 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,704 | $122 |
| Sleep study in sleep lab (6 years or older) | 14 | $1,168 | $83 |
| Test to determine lung volumes using sensors | 24 | $254 | $11 |
| Test to examine how well the lungs exchange gases | 24 | $188 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 17 | $176 | $10 |
| Test to measure expiratory airflow and volume | 20 | $151 | $8 |
2013: 10 services
| Critical care, first 30-74 minutes | 67 | $30,849 | $190 |
| Return visit (30+ min) | 75 | $5,038 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $3,119 | $62 |
| Sleep study in sleep lab (6 years or older) | 25 | $2,415 | $93 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 23 | $2,209 | $96 |
| Short return visit (20+ min) | 53 | $2,141 | $37 |
| Test to determine lung volumes using sensors | 19 | $208 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 17 | $184 | $10 |
| Test to examine how well the lungs exchange gases | 17 | $136 | $8 |
| Test to measure expiratory airflow and volume | 16 | $101 | $6 |
Medicaid work
$13,424 in 2024
Medicaid paid $13,424 for 2,354 billed services this clinician did in 2024, up to 76 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 154 | $6,664 |
| Short return visit (20+ min) | 343 | $3,816 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 44 | $1,031 |
| Return visit (30+ min) | 54 | $862 |
| New patient visit (30+ min) | 72 | $688 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 13 | $260 |
| Sleep study, unattended, simultaneous recording of, heart rate, oxygen saturation, respiratory airflow, and respiratory effort (eg, thoracoabdominal movement) | 84 | $79 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 13 | $13 |
| Diffusing capacity | 12 | $9 |
| Pain severity quantified; no pain present (COA) (ONC) | 23 | $0 |
| Medication list documented in medical record (COA) | 427 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 289 | $0 |
| 2024 | 2,354 | 18 | 76 | $13,424 |
| 2023 | 1,026 | 13 | 37 | $10,584 |
| 2022 | 216 | 6 | 19 | $7,264 |
| 2021 | 464 | 6 | 22 | $21,100 |
| 2020 | 240 | 2 | 20 | $11,387 |
| 2019 | 359 | 8 | 24 | $6,867 |
| 2018 | 475 | 9 | 24 | $12,286 |
See the largest Medicaid services in earlier years
2023
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 268 | $8,386 |
| Short return visit (20+ min) | 294 | $918 |
| Return visit (30+ min) | 48 | $309 |
| New patient visit (30+ min) | 32 | $288 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 14 | $253 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 78 | $169 |
| Diffusing capacity | 94 | $120 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 26 | $79 |
| Sleep study, unattended, simultaneous recording of, heart rate, oxygen saturation, respiratory airflow, and respiratory effort (eg, thoracoabdominal movement) | 25 | $47 |
| EVALUATION OF WHEEZING | 24 | $15 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 18 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 51 | $0 |
2022
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 145 | $7,051 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 12 | $205 |
| Return visit (30+ min) | 12 | $8 |
| Sleep study, unattended, simultaneous recording of, heart rate, oxygen saturation, respiratory airflow, and respiratory effort (eg, thoracoabdominal movement) | 13 | $0 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 19 | $0 |
| Short return visit (20+ min) | 15 | $0 |
2021
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 337 | $20,600 |
| Return visit (30+ min) | 26 | $213 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 13 | $134 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 34 | $76 |
| Diffusing capacity | 39 | $51 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 15 | $26 |
2020
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 225 | $11,300 |
| Return visit (30+ min) | 15 | $87 |
2019
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 116 | $5,747 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, with initiation of continuous positive airway pressure therapy or bilevel ventilation, attended by a technologist | 19 | $392 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 13 | $338 |
| Return visit (30+ min) | 68 | $236 |
| EVALUATION OF WHEEZING | 29 | $87 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 39 | $25 |
| Diffusing capacity | 34 | $22 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 41 | $21 |
2018
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 263 | $11,269 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 17 | $398 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 12 | $314 |
| Return visit (30+ min) | 41 | $116 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 40 | $72 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 39 | $43 |
| Diffusing capacity | 37 | $41 |
| EVALUATION OF WHEEZING | 14 | $35 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, with initiation of continuous positive airway pressure therapy or bilevel ventilation, attended by a technologist | 12 | $0 |
Drugs they prescribed that Part D paid
$112,708
Pharmacies billed $112,708 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 328) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.
145 generic and 183 brand-name prescriptions · $112,708 in drug cost · 23 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Spiriva Handihaler | 21 | $19,164 | $913 |
| Advair Hfa | 16 | $5,808 | $363 |
| Breo Ellipta | 15 | $5,374 | $358 |
| Tiotropium | 11 | $4,385 | $399 |
| Budesonide-Formoterol | 20 | $3,960 | $198 |
See all 13 drugs
| Spiriva Handihaler | 21 | $19,164 | $913 |
| Advair Hfa | 16 | $5,808 | $363 |
| Breo Ellipta | 15 | $5,374 | $358 |
| Tiotropium | 11 | $4,385 | $399 |
| Budesonide-Formoterol | 20 | $3,960 | $198 |
| Qvar Redihaler | 12 | $3,014 | $251 |
| Albuterol Sulfate Hfa | 53 | $2,150 | $41 |
| Fluticasone-Salmeterol | 16 | $1,476 | $92 |
| Ventolin Hfa | 13 | $677 | $52 |
| Prednisone | 23 | $134 | $6 |
| Fluticasone Propionate | 13 | $126 | $10 |
| Montelukast | 14 | $118 | $8 |
| Azithromycin | 13 | $94 | $7 |
Year by year
| 2024 | 328 | 72 | 0% (0) | 56% | $112,708 |
| 2023 | 279 | 59 | None | 69% | $90,556 |
| 2022 | 371 | 67 | 0% (0) | 84% | $151,809 |
| 2021 | 344 | 72 | None | 79% | $130,693 |
| 2020 | 386 | 77 | 0% (0) | 75% | $174,191 |
| 2019 | 307 | 84 | 0% (0) | 75% | $143,798 |
| 2018 | 333 | 91 | 0% (0) | 65% | $74,427 |
| 2017 | 354 | 79 | None | 71% | $149,544 |
| 2016 | 448 | 88 | 0% (0) | 75% | $305,824 |
| 2015 | 310 | 70 | None | 74% | $411,761 |
| 2014 | 393 | 76 | None | 72% | $339,933 |
| 2013 | 387 | 75 | None | 76% | $263,601 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Advair Diskus | 29 | $17,598 | $607 |
| Symbicort | 30 | $15,701 | $523 |
| Incruse Ellipta | 28 | $13,420 | $479 |
| Advair Hfa | 19 | $10,409 | $548 |
| Spiriva Handihaler | 12 | $7,742 | $645 |
| Albuterol Sulfate Hfa | 38 | $1,840 | $48 |
| Ventolin Hfa | 12 | $846 | $70 |
| Fluticasone Propionate | 13 | $233 | $18 |
| Prednisone | 13 | $76 | $6 |
2022: 9 drugs
| Spiriva Handihaler | 51 | $27,782 | $545 |
| Symbicort | 56 | $23,362 | $417 |
| Advair Hfa | 27 | $15,029 | $557 |
| Advair Diskus | 20 | $12,927 | $646 |
| Incruse Ellipta | 27 | $9,922 | $367 |
| Qvar Redihaler | 13 | $3,440 | $265 |
| Albuterol Sulfate Hfa | 41 | $2,291 | $56 |
| Ventolin Hfa | 18 | $752 | $42 |
| Fluticasone Propionate | 11 | $108 | $10 |
2021: 10 drugs
| Spiriva | 58 | $32,079 | $553 |
| Symbicort | 50 | $21,026 | $421 |
| Advair Diskus | 29 | $19,770 | $682 |
| Advair Hfa | 14 | $7,828 | $559 |
| Incruse Ellipta | 12 | $4,367 | $364 |
| Arnuity Ellipta | 14 | $2,511 | $179 |
| Albuterol Sulfate Hfa | 33 | $1,605 | $49 |
| Ventolin Hfa | 19 | $1,409 | $74 |
| Ipratropium | 11 | $317 | $29 |
| Montelukast | 11 | $154 | $14 |
2020: 9 drugs
| Ambrisentan | 11 | $67,621 | $6,147 |
| Spiriva | 66 | $38,383 | $582 |
| Advair Diskus | 31 | $20,420 | $659 |
| Symbicort | 42 | $16,704 | $398 |
| Incruse Ellipta | 22 | $7,662 | $348 |
| Ventolin Hfa | 33 | $2,130 | $65 |
| Albuterol Sulfate Hfa | 41 | $1,707 | $42 |
| Proair Hfa | 12 | $726 | $61 |
| Ipratropium | 14 | $459 | $33 |
2019: 10 drugs
| Spiriva | 30 | $19,344 | $645 |
| Advair Diskus | 22 | $12,361 | $562 |
| Symbicort | 23 | $10,212 | $444 |
| Breo Ellipta | 13 | $6,274 | $483 |
| Flovent Hfa | 17 | $5,347 | $315 |
| Incruse Ellipta | 11 | $3,710 | $337 |
| Ventolin Hfa | 41 | $2,577 | $63 |
| Proair Hfa | 15 | $730 | $49 |
| Azithromycin | 12 | $188 | $16 |
| Prednisone | 15 | $124 | $8 |
2018: 12 drugs
| Spiriva | 43 | $21,815 | $507 |
| Symbicort | 32 | $10,284 | $321 |
| Advair Diskus | 13 | $5,193 | $399 |
| Flovent Hfa | 20 | $4,155 | $208 |
| Incruse Ellipta | 11 | $3,616 | $329 |
| Levalbuterol Tartrate Hfa | 12 | $1,245 | $104 |
| Ventolin Hfa | 20 | $1,182 | $59 |
| Proair Hfa | 18 | $1,052 | $58 |
| Prednisone | 31 | $338 | $11 |
| Montelukast | 23 | $161 | $7 |
| Fluticasone Propionate | 17 | $158 | $9 |
| Pantoprazole | 13 | $85 | $7 |
2017: 9 drugs
| Spiriva | 59 | $25,012 | $424 |
| Symbicort | 37 | $10,011 | $271 |
| Flovent Hfa | 22 | $5,467 | $248 |
| Incruse Ellipta | 13 | $5,289 | $407 |
| Dulera | 13 | $3,658 | $281 |
| Ventolin Hfa | 36 | $1,992 | $55 |
| Proair Hfa | 14 | $783 | $56 |
| Fluticasone Propionate | 21 | $224 | $11 |
| Montelukast | 31 | $190 | $6 |
2016: 14 drugs
| Tracleer | 14 | $133,003 | $9,500 |
| Spiriva | 37 | $18,021 | $487 |
| Advair Diskus | 38 | $16,118 | $424 |
| Symbicort | 52 | $15,232 | $293 |
| Incruse Ellipta | 28 | $7,480 | $267 |
| Atrovent Hfa | 14 | $4,492 | $321 |
| Ventolin Hfa | 55 | $2,910 | $53 |
| Dulera | 12 | $2,855 | $238 |
| Qvar | 13 | $2,386 | $184 |
| Flovent Hfa | 11 | $2,144 | $195 |
| Xopenex Hfa | 21 | $1,470 | $70 |
| Proair Hfa | 17 | $883 | $52 |
| Fluticasone Propionate | 28 | $214 | $8 |
| Montelukast | 17 | $212 | $12 |
2015: 9 drugs
| Tracleer | 27 | $228,443 | $8,461 |
| Prolastin C | 13 | $120,704 | $9,285 |
| Spiriva | 48 | $18,403 | $383 |
| Advair Diskus | 31 | $15,784 | $509 |
| Qvar | 23 | $4,546 | $198 |
| Proair Hfa | 21 | $1,459 | $69 |
| Ventolin Hfa | 16 | $759 | $47 |
| Montelukast | 23 | $192 | $8 |
| Fluticasone Propionate | 18 | $159 | $9 |
2014: 14 drugs
| Tracleer | 25 | $189,574 | $7,583 |
| Prolastin C | 11 | $87,400 | $7,945 |
| Advair Diskus | 57 | $20,046 | $352 |
| Spiriva | 62 | $18,352 | $296 |
| Symbicort | 20 | $5,751 | $288 |
| Atrovent Hfa | 14 | $3,579 | $256 |
| Qvar | 13 | $2,305 | $177 |
| Ventolin Hfa | 31 | $1,378 | $44 |
| Proair Hfa | 26 | $1,065 | $41 |
| Fluticasone Propionate | 20 | $360 | $18 |
| Theophylline Anhydrous | 17 | $292 | $17 |
| Montelukast | 11 | $245 | $22 |
| Prednisone | 21 | $225 | $11 |
| Omeprazole | 14 | $123 | $9 |
2013: 12 drugs
| Tracleer | 16 | $109,527 | $6,845 |
| Prolastin C | 12 | $88,968 | $7,414 |
| Advair Diskus | 74 | $24,636 | $333 |
| Spiriva | 64 | $16,432 | $257 |
| Sildenafil | 12 | $8,708 | $726 |
| Atrovent Hfa | 26 | $4,715 | $181 |
| Proair Hfa | 51 | $2,342 | $46 |
| Qvar | 14 | $2,188 | $156 |
| Fluticasone Propionate | 12 | $358 | $30 |
| Montelukast | 13 | $318 | $24 |
| Omeprazole | 14 | $159 | $11 |
| Prednisone | 19 | $138 | $7 |
Money from drug and device companies
$22 in 2025
| 2025 | 1 | 1 | None | $22 |
| 2024 | 1 | 1 | None | $23 |
| 2019 | 2 | 2 | None | $238 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Actelion Pharmaceuticals US | Uptravi | $22 | 1 payment
|
See the published payment
| Actelion Pharmaceuticals US | Meals · 2025-05-07 | Uptravi | $22 |
See earlier years (2024, 2019)
2024: $23
| Actelion Pharmaceuticals US | Uptravi | $23 | 1 payment
|
2019: $238
| Boehringer Ingelheim Pharmaceuticals | Ofev | $123 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $115 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1982667606
- Licence
- CA A65453California A65453: Current · expires 2028-06-30
- Trained
- University of California, Irvine, California College of Medicine, 1996
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A654530
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 207RC0200X (207RC0200X); Federal specialty code 207RP1001X (207RP1001X)
- Mailing address
- 751 S Bascom Ave, San Jose, CA, 95128
- NPI first listed
- 2006-04-11
- NPI last updated
- 2007-08-31
This is when the NPI record was last certified, not a medical board exam.